Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.20
-0.78-4.59%
Pre-Market: 4:08 AM EDT
Comments
Loading...
MediWound Analyst Ratings and Price Targets | NASDAQ:MDWD | Benzinga
MediWound Ltd has a consensus price target of $26.33 based on the ratings of 6 analysts. The high is $39 issued by Craig-Hallum on February 28, 2025. The low is $8 issued by Wells Fargo on May 18, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Craig-Hallum, and HC Wainwright & Co. on March 20, 2025, February 28, 2025, and January 10, 2025, respectively. With an average price target of $29.67 between HC Wainwright & Co., Craig-Hallum, and HC Wainwright & Co., there's an implied 83.13% upside for MediWound Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Craig-Hallum
Oppenheimer
Cowen & Co.
Maxim Group
1calculated from analyst ratings
Analyst Ratings for MediWound
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | Buy Now | 54.32% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | Buy Now | 140.74% | Craig-Hallum | Chase Knickerbocker50% | → $39 | Initiates | → Buy | Get Alert |
| 01/10/2025 | Buy Now | 54.32% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/27/2024 | Buy Now | 54.32% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $28 → $25 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | 72.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | 72.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 07/16/2024 | Buy Now | 72.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 72.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/22/2024 | Buy Now | 72.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2024 | Buy Now | 72.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $26 → $28 | Maintains | Buy | Get Alert |
| 11/22/2023 | Buy Now | 60.49% | HC Wainwright & Co. | Swayampakula Ramakanth49% | → $26 | Reiterates | Buy → Buy | Get Alert |
| 09/21/2023 | Buy Now | 60.49% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $23 → $26 | Maintains | Buy | Get Alert |
| 08/17/2023 | Buy Now | 122.22% | Oppenheimer | Francois Brisebois44% | $63 → $36 | Maintains | Outperform | Get Alert |
| 08/17/2023 | Buy Now | 41.98% | HC Wainwright & Co. | Swayampakula Ramakanth49% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 05/31/2023 | Buy Now | 288.89% | Oppenheimer | Francois Brisebois44% | → $63 | Reiterates | Outperform → Outperform | Get Alert |
| 05/31/2023 | Buy Now | 41.98% | HC Wainwright & Co. | Swayampakula Ramakanth49% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 03/17/2023 | Buy Now | 41.98% | HC Wainwright & Co. | Swayampakula Ramakanth49% | → $23 | Reiterates | → Buy | Get Alert |
| 01/04/2023 | Buy Now | 41.98% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $5.5 → $23 | Maintains | Buy | Get Alert |
| 12/30/2022 | Buy Now | 54.32% | Cowen & Co. | Joshua Jennings55% | $6 → $25 | Maintains | Outperform | Get Alert |
| 12/22/2022 | Buy Now | 54.32% | Maxim Group | Michael Okunewitch25% | → $25 | Initiates | → Buy | Get Alert |
| 12/21/2022 | Buy Now | 288.89% | Oppenheimer | Francois Brisebois44% | $9 → $63 | Maintains | Outperform | Get Alert |
| 11/16/2022 | Buy Now | -66.05% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $42 → $38.5 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | -56.79% | Oppenheimer | Francois Brisebois44% | → $49 | Assumes | → Outperform | Get Alert |
| 05/18/2022 | Buy Now | -50.62% | Wells Fargo | Jacob Hughes52% | $49 → $56 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for MediWound (MDWD) stock?
The latest price target for MediWound (NASDAQ:MDWD) was reported by HC Wainwright & Co. on March 20, 2025. The analyst firm set a price target for $25.00 expecting MDWD to rise to within 12 months (a possible 54.32% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MediWound (MDWD)?
The latest analyst rating for MediWound (NASDAQ:MDWD) was provided by HC Wainwright & Co., and MediWound reiterated their buy rating.
When was the last upgrade for MediWound (MDWD)?
There is no last upgrade for MediWound
When was the last downgrade for MediWound (MDWD)?
There is no last downgrade for MediWound.
When is the next analyst rating going to be posted or updated for MediWound (MDWD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediWound, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediWound was filed on March 20, 2025 so you should expect the next rating to be made available sometime around March 20, 2026.
Is the Analyst Rating MediWound (MDWD) correct?
While ratings are subjective and will change, the latest MediWound (MDWD) rating was a reiterated with a price target of $25.00 to $25.00. The current price MediWound (MDWD) is trading at is $16.20, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.